Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-04-08 @ 8:31 PM
Study NCT ID:
NCT02028767
Status:
COMPLETED
Last Update Posted:
2015-07-24
First Post:
2014-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
None
Primary Completion Date:
2014-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-06
First Submit QC Date:
None
Study First Post Date:
2014-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-26
Results First Submit QC Date:
None
Results First Post Date:
2015-07-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-26
Last Update Post Date:
2015-07-24
Last Update Post Date Type:
ESTIMATED